Roman Šafránek

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 205 citations · Full text

Vitamin D Binding Protein Is Not Involved in Vitamin D Deficiency in Patients with Chronic Kidney Disease

Marta Kalousová, S Sulková, Oskar Zakiyanov et al. · BioMed Research International · 2015 · 45 citations · Full text

Effects of proteasome inhibitors MG132, ZL₃VS and AdaAhx₃L₃VS on protein metabolism in septic rats

Jana Kadlčíková, Milan Holeček, Roman Šafránek et al. · International Journal of Experimental Pathology · 2004 · 37 citations · Full text

Proteasome Inhibitors, Septic Rats, Leucine Oxidation +19

Effect of acute acidosis on protein and amino acid metabolism in rats

Roman Šafránek, Milan Holeček, Luděk Šprongl et al. · Clinical Nutrition · 2003 · 30 citations

Animal Physiology, Energy Metabolism, Biochemistry +7

Modulation of inflammatory response in sepsis by proteasome inhibition

Roman Šafránek, Nobuya Ishibashi, Youske Oka et al. · International Journal of Experimental Pathology · 2006 · 28 citations · Full text

Immunology, Immune Regulation, Cell Death +16